PPT-Simeprevir in HIV Coinfection,
Author : noah | Published Date : 2024-09-18
GT1 C212 Trial Phase 3 Treatment Naïve and Treatment Experienced Dieterich D et al Clin Infect Dis 201459157987 HIV Coinfection Source Dieterich D et al
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Simeprevir in HIV Coinfection," is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Simeprevir in HIV Coinfection,: Transcript
GT1 C212 Trial Phase 3 Treatment Naïve and Treatment Experienced Dieterich D et al Clin Infect Dis 201459157987 HIV Coinfection Source Dieterich D et al Clin. JAMA 20153131232 9 HIV Coinfection brPage 2br Source Osinusi A et al JAMA 20153131232 9 Ledipasvir Sofosbuvir in GT1 with HIV Coinfection NIAID ERADICATE Trial Features NIAID ERADICATE Trial Design Open label phase 2 using fixed dose combination o ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR + SMV placebo + PEG-IFN + RBV. Randomisation*. 1 : 1. Double-blind. ≥ 18 years. HCV genotype 1. HCV RNA ≥ 10,000 IU. /ml. Null or partial responders to . John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. Regional Pharmacy Director, NY/NJ AETC. Pharmacist, Albany Medical Center. Objectives. Discuss recent guidelines . changes for HIV infection. Using . patient cases, discuss the role of . Genotype . 1 . (. Viral . Relapsers. ). PROMISE . Trial. Phase . 3. Treatment. . Experienced. Forns. X. , . et al. . Gastroenterology. 2014;146:1669-79.e3.. Source: . Forns. X. , et al. Gastroenterology. 2014;146:1669-79.e3.. Treatment –Experienced Genotype . 1 . ASPIRE Trial. Phase . 3. Treatment. . Experienced. Z. euzem. S. , . et al. . Gastroenterol. . 2014;146:430-41.. Source: . Zeuzem. S. , et al. . Gastroenterol. versus . Telaprevir. . with PR in GT1 . ATTAIN Trial. Phase . 3. Treatment. . Experienced. Reddy KR. , . et al. . Lancet Infect Dis. 2015;15:27-35.. Source: Reddy KR. , et al. Lancet Infect Dis. 2015;15:27-35.. . + Sofosbuvir +/- Ribavirin in Genotype 1. COSMOS Trial. Phase . 2a, . Treatment . Naïve and Treatment Experienced. Treatment. Naïve and Treatment . Experienced. Lawitz. . E. , et al. Lancet. 2014;384;1756-65.. John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Regional Pharmacy Director, . NY/NJ AIDS Education and Training Center . Pharmacist, HIV Medicine, Albany Medical Center. www.hcvguidelines.org. Released 1/29/14!. Presented by: . Fabian Cretu, Beverly-Ann Oliver, Kristina Miclat, Maeryl Sumagang. PHM142. September 25, 2018. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV. . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. Amber Wheeler, MD. WIHS Scientific Meeting. June 30, 2014. Objectives. To discuss:. Background . Aims. Preliminary “rough” data. Future Directions. HIV-infected . persons have increased. odds of . Antiretroviral. Agents . in Adults and Adolescents . January 2016. AETC . NCRC . Slide Set. About This Presentation. 2. July 2016. www.aidsetc.org. These slides were developed using the April 2015 guidelines, and updated in . Go to: pollev.com/CCO2. or scan the QR code below. *All responses are anonymous and cannot be linked to individual participants.. Contemporary Management of HIV: Managing HIV in Viral Hepatitis Coinfection. Mark Sulkowski, . MD. Professor of Medicine. Medical Director, Viral Hepatitis Center . Johns Hopkins University. Baltimore Maryland USA. Liver disease is the second leading specific causes of death amongst HIV-positive individuals in the D:A:D study.
Download Document
Here is the link to download the presentation.
"Simeprevir in HIV Coinfection,"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents